Sclerosis  >>  rHIgM22  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rHIgM22 / Acorda
M22, NCT01803867: An Intravenous Infusion Study of rHIg in Patients With Multiple Sclerosis

Completed
1
72
US
rHIgM22, M22
Acorda Therapeutics, PRA Health Sciences
Multiple Sclerosis
10/14
01/15

Download Options